Chemed shareholders re-elect all 10 directors, ratify PwC, approve executive compensation

Item 5. Stockholder Proposal. The proposal requesting stockholder ratification of termination pay, was not approved with the following votes: Voted For 6,498,338 Against 6,890,605 Abstain 26,772 Broker non-votes 743,025

Item 1. Election of Directors. The following directors, who constitute the entire Board of Directors, were elected at the meeting by the votes indicated: Nominee For Against Abstentions Broker non-votes Kevin J. McNamara 13,177,032 221,781 16,901 743,025 Ron DeLyons 13,250,702 155,701 9,311 743,025 Patrick P. Grace 10,025,720 3,295,348 94,646 743,025 Christopher J. Heaney 13,026,990 379,514 9,210 743,025 Thomas C. Hutton 13,215,396 192,523 7,796 743,025 Andrea R. Lindell 12,704,541 623,870 87,304 743,025 Elaine McCarthy 13,392,362 15,603 7,749 743,025 John M. Mount Jr. 13,331,523 75,000 9,192 743,025 Thomas P. Rice 12,950,739 376,753 88,223 743,025 George J. Walsh III 11,270,147 2,137,074 8,493 743,025

Item 4. Frequency of advisory votes on executive compensation. The proposal to hold an advisory vote on frequency of advisory votes on executive compensation, was approved with the following votes: ‎ Voted One year 13,012,902 Two years 118,686 Three years 258,661 Abstain 25,465 Broker non-votes 743,025

Item 2. Ratification of Independent Accountants. The proposal to ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the company’s independent accountants for the year ending December 31, 2023, was approved with the following votes: Voted For 13,715,097 Against 436,826 Abstain 6,818 Broker non-votes -

Item 3. Executive Compensation. The proposal to approve, on a non-binding basis, the Company’s executive compensation program, was approved with the following votes: Voted For 10,359,330 Against 3,020,668 Abstain 35,717 Broker non-votes 743,025